Skip to content 
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's disease; and ML-009, a G-protein-coupled receptor 52 positive allosteric modulator for the treatment of hyperactivity, impulsivity and agitation-related disorders. The company also develops platform identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. MapLight Therapeutics, Inc. was formerly known as Alvarado Therapeutics, Inc. and changed its name to MapLight Therapeutics, Inc. in August 2019. MapLight Therapeutics, Inc. was incorporated in 2018 and is based in Redwood City, California. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| MPLT | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| MPLT | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
MapLight Therapeutics, Inc. Common Stock (MPLT) share price today is $18.85
Yes, Indians can buy shares of MapLight Therapeutics, Inc. Common Stock (MPLT) on Vested. To buy MapLight Therapeutics, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MPLT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of MapLight Therapeutics, Inc. Common Stock (MPLT) via the Vested app. You can start investing in MapLight Therapeutics, Inc. Common Stock (MPLT) with a minimum investment of $1.
You can invest in shares of MapLight Therapeutics, Inc. Common Stock (MPLT) via Vested in three simple steps:
The 52-week high price of MapLight Therapeutics, Inc. Common Stock (MPLT) is $20.86. The 52-week low price of MapLight Therapeutics, Inc. Common Stock (MPLT) is $12.24.
The price-to-book (P/B) ratio of MapLight Therapeutics, Inc. Common Stock (MPLT) is 0.00
The market capitalization of MapLight Therapeutics, Inc. Common Stock (MPLT) is $837.13M
The stock symbol (or ticker) of MapLight Therapeutics, Inc. Common Stock is MPLT
Link copied 
